Literature DB >> 12164686

Proliferative activity as measured by MIB-1 labeling index and long-term outcome of cerebellar juvenile pilocytic astrocytomas.

Karl Roessler1, Alexander Bertalanffy, Hussun Jezan, Achmed Ba-Ssalamah, Irene Slavc, Thomas Czech, Herbert Budka.   

Abstract

Proliferative activity of cerebellar juvenile pilocytic astrocytomas (CJPA) and its significance for prognosis was retrospectively investigated. Forty-four consecutive children operated between 1981 and 1997 with a mean age of 8.3 years (3 months to 20 years) were reviewed. Clinical and radiological follow-up was available for 38 patients ranging from 0 to 18 yrs (mean 6.3 years). Proliferative activity was determined by MIB-1 immunohistochemistry on sections of resected tumor specimen. Total resection was achieved in 35 children (79.5%), subtotal in 9 (20.5%). Currently, 31 are tumor-free, 6 have stable remnants, one developed spinal seeding and one died. Radiology revealed a cystic mural node type tumor in 27 patients (61.4%), a solid lesion with a small cyst in 5 patients (11.4%), and a solid tumor in 12 patients (27.3%). Mean MIB-1 labeling index (LI) of all tumors was 4.4% (range 0.6-12%, SD = 2.7) and did not correlate with age, gender, localization, amount of resection, follow-up status, histological appearence or grade of neovascularization, but showed a significant correlation to radiological types: 6.9% in solid tumors versus 3.7% in the cystic mural node type (p = 0.0037). Five year progression-free survival (PFS) of all patients was 84.4%, differences between subgroups of MIB-1 <5% (27 patients, PFS = 87.4%) and MIB-1 >5% (13 patients, PFS = 76.3%) were not significant. CJPA showed a remarkable high MIB-1 LI, but no significant correlation to PFS in this series. Nevertheless, radiologically solid tumors demonstrated a significantly higher MIB-1 LI and thus may need further investigation for possible increased ability of regrowth.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12164686     DOI: 10.1023/a:1016053229688

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  32 in total

1.  The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.

Authors:  P C Burger; T Shibata; P Kleihues
Journal:  Am J Surg Pathol       Date:  1986-09       Impact factor: 6.394

2.  Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation.

Authors:  J Gerdes; U Schwab; H Lemke; H Stein
Journal:  Int J Cancer       Date:  1983-01-15       Impact factor: 7.396

3.  Proliferative activity as measured by MIB-1 labeling index and long-term outcome of visual pathway astrocytomas in children.

Authors:  T Czech; I Slavc; M Aichholzer; C Haberler; W Dietrich; K Dieckmann; W Koos; H Budka
Journal:  J Neurooncol       Date:  1999-04       Impact factor: 4.130

Review 4.  The new WHO classification of brain tumours.

Authors:  P Kleihues; P C Burger; B W Scheithauer
Journal:  Brain Pathol       Date:  1993-07       Impact factor: 6.508

5.  Cystic cerebellar astrocytomas in childhood.

Authors:  T W Griffin; D Beaufait; J C Blasko
Journal:  Cancer       Date:  1979-07       Impact factor: 6.860

6.  Cerebral pilocytic astrocytoma.

Authors:  G B Clark; J M Henry; P E McKeever
Journal:  Cancer       Date:  1985-09-01       Impact factor: 6.860

7.  Grading of astrocytomas. A simple and reproducible method.

Authors:  C Daumas-Duport; B Scheithauer; J O'Fallon; P Kelly
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

8.  Benign cerebellar astrocytomas in children.

Authors:  P Pencalet; W Maixner; C Sainte-Rose; A Lellouch-Tubiana; G Cinalli; M Zerah; A Pierre-Kahn; E Hoppe-Hirsch; M Bourgeois; D Renier
Journal:  J Neurosurg       Date:  1999-02       Impact factor: 5.115

9.  Benign cerebellar astrocytomas of childhood.

Authors:  J H Schneider; C Raffel; J G McComb
Journal:  Neurosurgery       Date:  1992-01       Impact factor: 4.654

10.  Astrocytomas in childhood: a population-based study.

Authors:  G J Dohrmann; J R Farwell; J T Flannery
Journal:  Surg Neurol       Date:  1985-01
View more
  6 in total

Review 1.  Gamma Knife treatment of low-grade gliomas in children.

Authors:  Murat Şakir Ekşi; Baran Yılmaz; Akın Akakın; Zafer Orkun Toktaş; Ahmet Cemil Kaur; Mustafa Kemal Demir; Türker Kılıç
Journal:  Childs Nerv Syst       Date:  2015-07-15       Impact factor: 1.475

2.  Biologic tumor behavior in pilocytic astrocytomas.

Authors:  Muhittin Belirgen; Su Gulsun Berrak; Hilâl Ozdag; Suheyla Uyar Bozkurt; Emel Eksioglu-Demiralp; M Memet Ozek
Journal:  Childs Nerv Syst       Date:  2012-01-14       Impact factor: 1.475

Review 3.  Pediatric cerebellar astrocytoma: a review.

Authors:  Christopher M Bonfield; Paul Steinbok
Journal:  Childs Nerv Syst       Date:  2015-09-09       Impact factor: 1.475

Review 4.  Pediatric low-grade gliomas: how modern biology reshapes the clinical field.

Authors:  Guillaume Bergthold; Pratiti Bandopadhayay; Wenya Linda Bi; Lori Ramkissoon; Charles Stiles; Rosalind A Segal; Rameen Beroukhim; Keith L Ligon; Jacques Grill; Mark W Kieran
Journal:  Biochim Biophys Acta       Date:  2014-02-28

5.  In pursuit of prognostic factors in children with pilocytic astrocytomas.

Authors:  Aline Paixão Becker; Ricardo Santos de Oliveira; Fabiano Pinto Saggioro; Luciano Neder; Leila Maria Cardão Chimelli; Hélio Rubens Machado
Journal:  Childs Nerv Syst       Date:  2009-10-13       Impact factor: 1.475

6.  Expression of oligodendroglial differentiation markers in pilocytic astrocytomas identifies two clinical subsets and shows a significant correlation with proliferation index and progression free survival.

Authors:  Hidehiro Takei; Subashini T Yogeswaren; Kwong-Kwok Wong; Vidya Mehta; Murali Chintagumpala; Robert C Dauser; Ching C Lau; Adekunle M Adesina
Journal:  J Neurooncol       Date:  2007-08-10       Impact factor: 4.506

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.